Enalare Therapeutics is a privately owned clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions. We have assembled a talented team with extensive pharmaceutical experience across all critical functions, focused on advancing our innovative products through development, regulatory review and launch.
© 2021 Enalare Therapeutics Inc.